Kinase Inhibitors Market
Kinase Inhibitors Market Size, Share & Trends Analysis Report
Kinase Inhibitors Market Size, Share, Statistics & Trends Analysis By Type (Tyrosin Kinase Inhibitors, VEGFR, PDGFR, EGFR, ALK, HER2, Mulikinase Inhibitors, Cabozantinib, Imatinib, Lenvatinib, Regorafenib, mTOR Kinase Inhibitors, Sirolimus, Everolimus, Temsirolimus, Others) By Route of Administration, Oral, Parenteral, Others) By End User (Hospitals, Homecare, Specialty Clinics, Others) By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) Other Based On Region, And Segment Forecasts, 2025 – 2031
Published
Report ID : BMEC 4665
Number of pages : 300
Published Date : Apr 2025
Category : Pharmaceutical
Delivery Timeline : 48 hrs
Key Players
- Novartis AG (Switzerland)
- Endo International Inc (Ireland)
- Teva Pharmaceutical Industries Ltd (Israel)
- Glenmark Pharmaceuticals Ltd (India)
- Cipla Inc (India)
- Dr Reddy's Laboratories Ltd (India)
- Abbott (U.S.)
- Hoffmann-La Roche Ltd (Switzerland)
- Pfizer Inc (U.S.)
- Lupin (India)
- Takeda Pharmaceutical Company Limited (Japan)
- Akorn, Incorporated (U.S.)
- Torrent Pharmaceuticals Ltd. (India)
- Amneal Pharmaceuticals LLC. (U.S.)
- Astellas Pharma Inc. (Japan)
- Sierra Oncology, Inc (Canada)
Market Segmentation
By Type
- Tyrosin Kinase Inhibitors
- VEGFR
- PDGFR
- EGFR
- ALK
- HER2
- Mulikinase Inhibitors
- Cabozantinib
- Imatinib
- Lenvatinib
- Regorafenib
- mTOR Kinase Inhibitors
- Sirolimus
- Everolimus
- Temsirolimus
- Others
By Route of Administration
- Oral
- Parenteral
- Others
By End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
By Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
SUMMARY
Segments
Market Segmentation
By Type
- Tyrosin Kinase Inhibitors
- VEGFR
- PDGFR
- EGFR
- ALK
- HER2
- Mulikinase Inhibitors
- Cabozantinib
- Imatinib
- Lenvatinib
- Regorafenib
- mTOR Kinase Inhibitors
- Sirolimus
- Everolimus
- Temsirolimus
- Others
By Route of Administration
- Oral
- Parenteral
- Others
By End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
By Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Key Players
- Novartis AG (Switzerland)
- Endo International Inc (Ireland)
- Teva Pharmaceutical Industries Ltd (Israel)
- Glenmark Pharmaceuticals Ltd (India)
- Cipla Inc (India)
- Dr Reddy's Laboratories Ltd (India)
- Abbott (U.S.)
- Hoffmann-La Roche Ltd (Switzerland)
- Pfizer Inc (U.S.)
- Lupin (India)
- Takeda Pharmaceutical Company Limited (Japan)
- Akorn, Incorporated (U.S.)
- Torrent Pharmaceuticals Ltd. (India)
- Amneal Pharmaceuticals LLC. (U.S.)
- Astellas Pharma Inc. (Japan)
- Sierra Oncology, Inc (Canada)
